O

Oncolytics Biotech
D

ONCY

0.95410
USD
-0.03
(-2.64%)
Market Closed
Volume
20,277
EPS
-0
Div Yield
-
P/E
-4
Market Cap
73,536,388
OverviewSignalsIdeasNews
Related Instruments
    B
    BLU
    -0.02500
    (-0.33%)
    7.49000 USD
    C
    CRVS
    -0.31000
    (-3.64%)
    8.21000 USD
    I
    IMGN
    0
    (0%)
    0.000000 USD
    M
    MGNX
    -0.23000
    (-6.04%)
    3.58000 USD
    O
    ONTX
    0
    (0%)
    0.000000 USD
    P
    PKI
    1.920
    (1.57%)
    124.190 USD
    More
News

Title: Oncolytics Biotech

Sector: Healthcare
Industry: Biotechnology
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.